Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism

Keyphrases

• Pharmacy 100%
• Anticoagulants 100%
• Thromboembolism 100%
• Bleeding 66%
• Coagulation 66%
• Hemostasis 66%
• Bleeding Risk 66%
• Contact Path 66%
• Thrombosis 33%
• Life-threatening 33%
• Physiologic 33%
• Comorbidity 33%
• In Care 33%
• Undertreated 33%
• Novel Agents 33%
• Venous Thrombosis 33%
• Arterial Thrombosis 33%
• Anticoagulant Treatment 33%
• Bleeding Complications 33%
• Clinical Data 33%
• Anticoagulant Therapy 33%
• Direct Oral Anticoagulants 33%
• Increased Safety 33%
• Common Pathway 33%
• Unmet Medical Need 33%
• Coagulation Factors 33%
• Anticoagulant Drugs 33%
• Tissue Factor 33%
• Factor VIIa 33%
• Hemorrhagic Complications 33%
• Safety Efficacy 33%

Medicine and Dentistry

• Bleeding 100%
• Thromboembolism 100%
• Anticoagulant 100%
• Anticoagulant Therapy 66%
• Blood Stasis 66%
• Disease 33%
• Thrombosis 33%
• Phlebothrombosis 33%
• Artery Thrombosis 33%
• Antithrombotic 33%
• Direct Oral Anticoagulant 33%
• Blood Clotting Factor 33%
• Factor XI 33%
• Thromboplastin 33%
• Factor XII 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Thromboembolism 100%
• Bleeding 50%
• Blood Stasis 33%
• Direct Oral Anticoagulant 16%
• Comorbidity 16%
• Vein Thrombosis 16%
• Artery Thrombosis 16%
• Blood Clotting Factor 16%
• Blood Clotting Factor 12 16%
• Disease 16%
• Thrombosis 16%
• Thromboplastin 16%
• Blood Clotting Factor 11 16%